Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, May 14, 2024 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

SAN MATEO, Calif. - A multiple sclerosis patient claims she got malignant myeloma from taking Biogen Idec's and Elan Pharmaceuticals' drug Tysabri (natalizumab).

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.